IAS ANALYSIS Launches MONET-R FT-NIR Analyzer: A Breakthrough in High-End Lab Instruments from China
April 17, 2026
Independent R&D, global vision - the MONET-R brings precision, intelligence, and award-winning design to laboratories worldwide. Wuxi, China - IAS Global Co., Ltd. today announced the global launch of the MONET-R FT-NIR Analyzer, a fully self-developed high-performance laboratory-grade instrument designed to redefine intelligent detection across industries. The announcement was made during a live-streamed event commemorating [...]
Revolune and MindPeak to Showcase Integrated Multiplex Immunofluorescence Workflow at AACR 2026
April 16, 2026
Partnership highlights streamlined spatial biology workflows combining advanced multiplex IF reagents and AI-powered image analysis OBERKOCHEN, Germany -- Revolune GmbH, a life science company focused on simplifying spatial biology through streamlined multiplex immunofluorescence (mIF) reagents, today announced it will exhibit at the American Association for Cancer Research (AACR) Annual Meeting 2026 together with MindPeak, a leader in AI-powered pathology analysis. [...]
Promega to Showcase Oncology Research Tools and Companion Diagnostics at AACR Annual Meeting 2026
April 16, 2026
Bioluminescence tools, companion diagnostics and automated sample preparation headline Promega presence at AACR 2026 MADISON, Wis. -- Promega Corporation, a Madison, Wisconsin-based life science tools company, will present new technologies for cell health, target engagement and oncology diagnostics at the AACR Annual Meeting 2026 in San Diego, April 17-22. Researchers attending the conference can explore [...]
QIAGEN to Showcase New Sample to Insight Solutions for Complex Oncology Applications at AACR 2026
April 16, 2026
Highlights solutions addressing key oncology research needs across automated sample preparation, single-cell analysis, genomic profiling and data analysis QIAsymphony Connect will serve as a foundation for lab workflows, enabling standardized nucleic acid extraction for clinical and translational research Introduction of the QIAGEN Discovery Platform, an AI-grounding solution to power downstream AI applications and support drug [...]
April 16, 2026
Nanion Technologies GmbH Munich, Germany Following several years of close collaboration, Nanion Technologies and Elements are proud to announce the successful integration of Elements’ cutting-edge microchip-based amplifier technology into Nanion’s newly launched Patchlinere and Patchlinerm platforms. Driving innovation in electrophysiology Nanion has long been committed to advancing automated patch clamp technologies to accelerate drug discovery [...]
Eurobio scientific signs definitive agreement to acquire CareDx’s transplant Lab Product division
April 16, 2026
Acquisition of CareDx’s ‘lab products’ portfolio creates new opportunities for growth and innovation in the fast growing transplant diagnostics market Acceleration of Eurobio’s strategic plan to become an in-vitro molecular diagnostics (“IVD”) leader Creation of a global leading provider of kits for transplantation genomics Acquisition of a 100% proprietary products portfolio Deeper capabilities and larger [...]
April 16, 2026
Illumina launches DRAGEN v4.5, unlocking deep biological signals in complex regions and challenging sample types for rare disease, oncology research New pangenome representation, default personalization, and machine learning features boost analytical capabilities across applications SAN DIEGO -- Illumina Inc. (NASDAQ: ILMN) today announced the launch of DRAGEN™ version 4.5 software (v4.5), one of the most [...]
April 16, 2026
A next-generation PCR system designed to help labs manage increasing workflow complexity with greater flexibility, speed and confidence in reproducible results WALTHAM, Mass. -- Thermo Fisher Scientific Inc., the world leader in serving science, today announced the Applied Biosystems™ PowerFlex™ Thermal Cycler, a next-generation polymerase chain reaction (PCR) instrument designed to help deliver enhanced flexibility, [...]
April 16, 2026
SAN DIEGO and NEW YORK -- SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine, today announced that the Mount Sinai Health System, one of the leading academic health systems in the United States, will adopt the AI-powered SOPHiA DDM™ Platform to advance cancer research and enhance genomic testing capabilities. Mount Sinai, a National [...]
Araceli Biosciences Appoints Christine Tsingos to Board of Directors
April 16, 2026
Former Bio-Rad EVP & CFO brings deep sector, financial, and governance experience to support Araceli’s next phase of growth PORTLAND, Ore. — Araceli Biosciences today announced the appointment of Christine A. Tsingos to its Board of Directors, adding a seasoned public company executive with extensive experience in financial leadership, governance, and strategic growth. Tsingos brings more than 30 years [...]

